| 1. |
慢性阻塞性肺疾病急性加重診治專家組.慢性阻塞性肺疾病急性加重診治中國專家共識(2014年修訂版).國際呼吸雜志, 2014, 34:1-11.
|
| 2. |
Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax, 2008, 63:487-492.
|
| 3. |
陳絞, 楚世峰, 陳乃宏.糖皮質激素與抑郁發病相關機制研究發展.中國藥理學通報, 2013, 29:1493-1495.
|
| 4. |
Hayashi Y, Senjyu H, Iguchi A, et al. Prevalence of depressive symptoms in Japanese male patients with chronic obstructive pulmonary disease. Psychiatry Clin Neurosci, 2011, 65:82-88.
|
| 5. |
Tetikkurt C, Ozdemir I, Tetikkurt S, et al. Anxiety and depression in COPD patients and correlation with sputum and BAL cytology. Multidiscip Resp Med, 2011, 6:226-231.
|
| 6. |
Negi H, Sarkar M, Raval AD, et al. Presence of depression & its risk factors in patients with chronic obstructive pulmonary disease. Indian J Med Res, 2014, 139:402-408.
|
| 7. |
Yellowless PM, Alpers JH, Bodew JJ, et al. Psychiatric morbidity in patients with chronic airflow obstruction, Med J Aust 1987, 146:305-307.
|
| 8. |
盧冠男, 周寧, 鄧園, 等.老年慢性阻塞性肺疾病患者抑郁相關因素調查分析.國際呼吸雜志, 2010, 30:13-15.
|
| 9. |
Al-shair K, Kolsum U, Dockry R, et al. Biomakers of systemic inflammation and depression and fatigue in modertate clinically stable COPD. Respir Res, 2011, 12:3.
|
| 10. |
Luqer TM, Suls J, Vander Weg MW. How robust is the association between smoking and depression in adults? A meta-analysis using linear mixed-effects models. Addict Behav, 2014, 39:1418-1429.
|
| 11. |
Anacker C, Zunszain PA, Carvalho LA, et al. The glucocorticoid receptor:pivot of depression and of antidepressant treatment? Psychoneuroendocrinology, 2011, 36:415-425.
|
| 12. |
Kishnan V, Nestler EJ. The molecular neurobiology of depression. Nature, 2008, 455:894-902.
|
| 13. |
鐘南山, 蔡闖.慢性阻塞性肺疾病與焦慮抑郁的關系.繼續醫學教育, 2007, 21:17-19.
|
| 14. |
李佳倩, 章璐, 陳芳, 等.慢性阻塞性肺疾病患者生活質量評估研究近況.現代醫藥衛生, 2012, 28:2481-2482.
|
| 15. |
Lou PA, Zhu Y, Chen PP, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China:a cross-sectional case control study. BMC Pulmon Med, 2012, 12:53.
|
| 16. |
Ottenheim NR, Giltay EJ, Zitman FG, et al. Risk of depressive symptoms in the oldest old subjects with chronic obstructive pulmonary disease:the Leiden 85-plus study. Am J Geriatr Psychiatry, 2010, 18:388-394.
|
| 17. |
王玉鋒, 侯公林.抑郁癥近代藥物治療.第四軍醫大學學報, 2006, 27:1526-1528.
|
| 18. |
Chuluunkhuu G, Nakahara N, Yanagisawa S, et al. The efficacy of reboxetine as an antidepressant, a meta-analysis of both continuous and dichotomous outcomes. Kobe J Med Sci, 2008, 54:E147-158.
|
| 19. |
陳元成, 胥衛川.萬拉法辛與氟西汀治療抑郁焦慮癥狀的臨床對照研究.中國現代應用藥學雜志, 2008, 25:737-738.
|
| 20. |
梁穎華, 王冬梅, 楊得坡, 等.貫葉金絲桃素及其衍生物的合成與神經藥理學研究進展.中草藥, 2007, 38:789-791.
|
| 21. |
Fritzsche A, Clamor A, von Leupoldt A. Effects of medical and psychological treatment of depression in patients with COPD--a review. Respir Med, 2011, 105:1422-1433.
|
| 22. |
張少麗, 石少波.抑郁癥治療的研究進展.精神醫學雜志, 2008, 21:156-160.
|
| 23. |
Yohannes AM. Palliative care provision for patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes, 2007, 5:17.
|